Changes in the proportion and function of immune cells such as CD8+ T cells, regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment directly impact immune evasion and treatment response in tumors 42-44. This evidence concerns the gene CD8A and neoplasm.